FDA Describes Emergency Use Authorization Process In Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA draft guidance sets out expectations for emergency use authorization submissions for in vitro diagnostics and personal protective equipment, among other product types, during an emergency involving an infectious disease or terrorism attack with a chemical, biological, radiological or nuclear agent.